Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
83 Cards in this Set
- Front
- Back
Physical Agents |
group of procedures using various forms of energy that are applied in systematic manner |
|
NAGI Model |
1965, pathology -> impairment -> functional limitations -> disability |
|
disability |
inability or limitation in actions usually expected in social roles that are customary to a person's status |
|
functional limitation |
restriction of ability to perform at level as a whole person in efficient manner |
|
impairment |
loss or abnormality in anatomic, physiologic or psychologic structure or function (swelling, pain) |
|
ICIDH Model |
WHO 1980, disease -> impairment -> disability -> handicap |
|
ICF Model |
2001, enablement model -------------> health condition ------------------> | body funct/struct <-> activity <-> particp| | environment + personal factors
can intervene at any leveI |
|
Goal of Inflammation |
Days 1-6. Controls effect of injury, dispose of microorganisms and foreign material, prepares area for repair, red and ready |
|
Signs of Inflammation |
redness, increased temperature, pain, swelling, loss of function |
|
Vascular Response to Injury |
occurs during inflammation: edema formation, initial vasoconstriction (5-10 mins), vasodilation, increase in histamine, increase in capillary permability, prostaglandin makes capillaries leaky |
|
margination and pavementing of WBC |
occurs during vascular response of inflammation stage, WBC stick and build up on vessel wall, neutrophils are first to arrive |
|
capillary hydrostatic pressure |
push fluids out of capillaries (arteriole end), increased in injury |
|
interstitial osmotic pressure |
pulls fluid in to capillaries in an attempt to dilute (venule end), increased in compression |
|
Hemostatic Response to Injury |
Co-occurs during inflammation, temporary plug to control blood loss (scab), small vessels retract due to norepinephrine, platelets aggregate, fibrin deposits and traps RBC to form clot, attracts monocytes, macrophages, neutrophils and fibroblasts, gives tensile strength to wound |
|
Cellular Response to Injury |
Occurs during inflammation, leukocytes are key Early: PMN, neutrophils die and release digestive chemicals Late: monocytes come to convert to macrophage |
|
Macrophage |
attract fibroblast, catalyst to move out of inflammation onto next stage, need oxygen |
|
Immune Response during injury |
occurs during inflammation, fights infection, cell mediated by leukocytes and T-lymphocytes, complement system: series of enzymatic proteins activated by antibody/antigen association and bacterial toxins from cells. MAC membrane attack complex is end product. Results: increased vascular permability, phagocytosis, chemotaxis of leukocytes |
|
Poliferation |
day 3-20, re-epithelialization, fibroplasia, wound contraction, neovascularization |
|
re-epithelialization |
regrowth of skin, basal cells detach from basement membrane and divide and move, migrate while holding parent cells, continue until the pull wound closed, superficial, can occur within 24-48 hrs for small wounds |
|
fibroplasia |
collagen production, allows for more tensile strength, immature, weak, day 21 is max production but 20% strength, 6 weeks 80% strength, need oxygen, just the right amount of stress and repair |
|
wound contraction |
myoblasts, pulls edges of the wound together, creates scar tissue, pulls edges together from all sides |
|
neovascularization |
endothelial buds and capillary loops, development of new blood vessels in area, old vessels may make new branches, granulation tissue, macrophages stimulate growth, looks pink/red |
|
Maturation |
Day 9 onward, fibroblasts disappear, balance of synthesis and lysis, remodeling along stress lines, weak hydrogen bonds replaced with covalent bonds, blood vessels disappear, water content decreases |
|
keloid scar |
scar extends beyond borders of original injury |
|
hypertrophic |
extra scar tissue within border of original injury |
|
Acute pain |
recent onset, short/predictable course, know the cause usually, correlated with inflammation, reminder not to use part, less than 3-6 mo |
|
chronic pain |
more than 3-6 months, original injury is healed, unknown cause sometimes, generally inflammation gone, not proportional to damage, psychological component, oversensitivity to pain |
|
hyperalgesia |
heightened stimulus |
|
allodynia |
something that should not be painful at all is painful |
|
Specificity Theory of Pain |
There is a specific receptor for every sensation, pain has own receptor, does not explain how pain in minimized |
|
Pattern Theory of Pain |
one kind of receptor but pain is determined by action potentials increasing in frequency |
|
Gate Control Theory |
receptors fire in patters but there are also specific types of receptors and free nerve endings which sense specific sensations, balance of excitatory and inhibitory |
|
nonnociceptive nerves |
sense not painful, good sensation, flower spray endings, mechanorecepts, pacinian, corpuscles, |
|
nociceptive nerve |
sense pain, activated by substance P |
|
Substance P |
attracts bradykinens and changes polarization to create action potential in nearby place to send sensation of pain |
|
A Delta fibers |
20% of nociceptors, myelinated with small diameter, 30 m/s, quick sharp pain |
|
C Fibers |
80% nociceptors, large diameter, 1-4 m/s, nonmyelinated, slow dull ache, bradykinens and prostiglandins cause firing |
|
A Beta Fibers |
nonnociceptors, not painful, large diameter, myelinated, 20-90 m/s |
|
Anterolateral System |
ascending system for sensory information, carry conscious info of pain, temperature and touch both well and poorly localized Indirect: lateral spinothalamic and anterospinothalamic Direct: spinoreticulothalamis |
|
Substantia gelatinosa (SG) |
interneurons, not affected by A delta or C fibers, activated by A beta to send info to T cell |
|
T Cell |
gate to pain, receives messages from SG and sends to brain, can be inhibited by A beta via the SG and is excited by A delta and C fibers |
|
lateral spinothalamic |
part of the anterolateral system, fast, noxious/sharp pain, not many stops, localized |
|
anterospinothalamic |
part of the anterolateral system, cruder, less localized, achey pain, many stops |
|
spinoreticulothalamic |
diffuse, poorly localized |
|
2nd order neuron |
t-cell to thalamus, anterolateral system |
|
first order neuron |
t-cell and SG |
|
Central pathways: brainstem to brain |
reticular formation, raphe nucleus of brainstem, periaqueductal gray matter of midbrain, limbic system, hypothalamus |
|
reticular formation |
brainstem to midbrain: arousal |
|
raphe nucleus of brainstem |
produces body's opiods and more importantly seratonin |
|
periaqueductal gray matter of midbrain |
manufactures and has receptors for opioids: endorphins and enkephalins |
|
limbic system |
emotion control, produce opioids |
|
hypothalamus |
ANS, controls mood, diencephalon |
|
3rd Order Neurons |
from thalamus (relay center for pain) to cortex (post central gyrus) |
|
Descending Pain Control Mechanism |
endogenous opiate theory: end endorphins for four hours and enkephalins for half hour descending neurotransmitters: serotonin and norepinephrine influence T Cells |
|
Chronic Pain |
hyperirritability, decreased threshold, increased efferent output, viscerosomatic and somatovisceral connection, pain-spasm-pain cycle |
|
pain-spasm-pain cycle |
when a lot of A delta comes in quicky signal is sent to T cell and T cell sends signal to brain and to muscles to contract, muscle contraction causes more pain which causes more contraction, need to break cycle. |
|
treatments to decrease pain |
stimulate A beta fiber with a modality or technique, brief intense treatment to stimulate opioid, prolonged c fiber stimulation to stimulate endorphin release |
|
frequency of ultrasound |
above 20,000 Hz for therapy typically .7 to 3.3 MHz for depth of 2-5 cm |
|
attenuation |
ultrasound decreases in intensity as it travels through a material, 1/2 due to absorption, increases with collagen content |
|
continuous ultrasound |
used to produce thermal effects |
|
piezoelectric |
responds to the alternating current by expanding and contracting (in transducer of ultrasound machine) |
|
thermal effects of ultrasound |
increase temperature of deep and superficial tissues (proportional to coefficient of absorption and frequency), 3 MHz heats more but not as deep (1-2cm), 1 MHz heats less but deeper (3-5cm), SATP .5 W/cm^2 or greater |
|
duty cycle |
the proportion of the total treatment time that the ultrasound is on, can be either percentage or ratio, 1:5 means on 20% of the time and off 80% of the time |
|
spatial average temporal average (SATA) intensity |
the average output over the area of the transducer over the average of the on and off time |
|
Nonthermal effects of Ultrasound |
due to mechanical events, delivered in pulse mode with 20% or lower duty cycle, increase intracellular calcium levels, increase skin and cell permeability, increases histamine and chemotatic factor, promote macrophage response, can help heal fractures
SATP .1-.2 W/cm^2 1Mhz |
|
phonophoresis |
transdermal drug delivery using sound |
|
contraindications of ultrasound |
malignant tumor, pregnancy, over CNS tissue, joint cement, pacemaker, thromophlebitis, eyes, reproductive organs, plastic componenets |
|
adverse effects of ultrasound |
periosteal burn, burn in areas of impaired sensation, damage to epithelial lining of blood vessels, transmission of infection |
|
precautions of ultrasound |
acute inflammation, epiphyseal plates, fractures, breast implants |
|
acoustic streaming |
steady, circular dlow of cellular fluids induced by ultrasound |
|
cavitation |
the formation, growth and pulsation of gas-filled bubbles caused by ultrasound, expand during rarefaction and shrink during compression |
|
standing wave |
occur when the ultrasound transducer and reflecting surface are exact multiples of wavelengths apart, allowing reflecting wave to superimpose on incident wave |
|
effective radiating area |
ERA, area of transducer from which ultrasound energy radiates |
|
intensity of ultrasound |
power per unit area (W/cm^2) |
|
spacial average temporal peak |
SATP, average intensity/ERA, no heat when under .5W/cm^2 |
|
physical properties of water |
buoyancy, specific heat/thermal conductivity, resistance/viscosity, hydrostatic pressures
|
|
physiological effects of hydrotherapy |
cleansing (softens materials and exerts pressure), less trauma in weight bearing exercises, provide force in exercise (resistance), increases venous return (60% when in up to neck), decrease in heart rate, increases resistance to lung expansion, increased urine production, calming effect |
|
uses of hydrotherapy (5) |
superficial heating and cooling, exercise, edema control, wound care, burn care, |
|
contraindication of hydrotherapy (8) |
maceration around a wound (immersion), bleeding (immersion), superficial hot and cold contraindications
whole body: cardiac instability, infectious condition, bowel incontinence, severe epilepsy, suicidal patients |
|
adverse reactions of hydrotherapy (6) |
drowning, heat reactions (burning, fainting, bleeding), hyponatremia (loss of salt w/ burn patient), infection, aggravation of edema, exacerbation of asthma (if allergic to chemicals) |
|
hyperemia |
increase in blood to area causing increase in temp |
|
chronic inflammation |
simultaneous active inflammation, tissue destruction and healing (mononuclear cells and fibroblasts)
caused by reinjury, disease or infection |
|
factors affecting tissue healing ( 8) |
type/size/location, infection, vascular supply, movement, age, disease, medication, nutrition |